Re: Separation from Employment and General ReleaseSeparation Agreement • May 19th, 2023 • Diffusion Pharmaceuticals Inc. • Pharmaceutical preparations
Contract Type FiledMay 19th, 2023 Company IndustryThis letter agreement and general release (this “Agreement”) sets forth the terms of your separation from employment with Diffusion Pharmaceuticals Inc. (together with its subsidiaries, “Diffusion” or the “Company”) effective May 15, 2023 (the “Separation Date”). References in this Agreement to “you” and “your” refer to Mr. William Hornung.
Re: Separation from Employment and General ReleaseSeparation Agreement • May 19th, 2023 • Diffusion Pharmaceuticals Inc. • Pharmaceutical preparations
Contract Type FiledMay 19th, 2023 Company IndustryThis letter agreement and general release (this “Agreement”) sets forth the terms of your separation from employment with Diffusion Pharmaceuticals Inc. (together with its subsidiaries, “Diffusion” or the “Company”) effective May 15, 2023 (the “Separation Date”). References in this Agreement to “you” and “your” refer to Mr. William Hornung.
Re: Separation from Employment and General Release Dear Raven,Separation Agreement • March 24th, 2023 • Diffusion Pharmaceuticals Inc. • Pharmaceutical preparations
Contract Type FiledMarch 24th, 2023 Company IndustryThis letter agreement and general release (this “Agreement”) sets forth the terms of your separation from employment with Diffusion Pharmaceuticals Inc. (together with its subsidiaries, “Diffusion” or the “Company”) effective March 1, 2023 (the “Separation Date”). References in this Agreement to “you” and “your” refer to Ms. Raven Jaeger, M.S.
Re: Separation from Employment and General Release Dear Chris,Separation Agreement • March 24th, 2023 • Diffusion Pharmaceuticals Inc. • Pharmaceutical preparations
Contract Type FiledMarch 24th, 2023 Company IndustryThis letter agreement and general release (this “Agreement”) sets forth the terms of your separation from employment with Diffusion Pharmaceuticals Inc. (together with its subsidiaries, “Diffusion” or the “Company”) effective March 1, 2023 (the “Separation Date”). References in this Agreement to “you” and “your” refer to Dr. Christopher D. Galloway, M.D.
Re: Separation from Employment and General ReleaseSeparation Agreement • February 16th, 2023 • Diffusion Pharmaceuticals Inc. • Pharmaceutical preparations
Contract Type FiledFebruary 16th, 2023 Company IndustryThis letter agreement and general release (this “Agreement”) sets forth the terms of your separation from employment with Diffusion Pharmaceuticals Inc. (together with its subsidiaries, “Diffusion” or the “Company”) effective March 1, 2023 (the “Separation Date”). References in this Agreement to “you” and “your” refer to [_____].